Literature DB >> 20817062

Temporal expression of P2X7 purinergic receptor during the course of experimental autoimmune encephalomyelitis.

Tomasz Grygorowicz1, Lidia Struzyńska, Grzegorz Sulkowski, Małgorzata Chalimoniuk, Dorota Sulejczak.   

Abstract

Purinergic P2X(7) receptors are nucleotide-gated ion channels widely distributed in brain. Strong evidence suggests that they are involved in cross-talk between glial and neuronal cells. These receptors activated under pathological conditions may participate in regulation of inflammatory response and cell death. In this study we show the expression of P2X(7) protein and mRNA during the course of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), in different stages of the disease (4, 6, 8, 10 post-immunization). The enhanced expression of the receptor at the level of both mRNA and protein was observed in the peak of neurological symptoms and was connected mostly with neurons. However, early overexpression of receptor protein was observed also in an asymptomatic phase of EAE and was tightly related to astrocytic pool of cells. This suggests the early involvement of this kind of receptor into pathological mechanisms leading for symptoms characteristic for EAE.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20817062     DOI: 10.1016/j.neuint.2010.08.021

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  13 in total

Review 1.  Neuronal P2X7 Receptors Revisited: Do They Really Exist?

Authors:  Peter Illes; Tahir Muhammad Khan; Patrizia Rubini
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

2.  Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.

Authors:  Junbin Han; Hui Liu; Chunling Liu; Hongjun Jin; Joel S Perlmutter; Terrance M Egan; Zhude Tu
Journal:  Nucl Med Commun       Date:  2017-05       Impact factor: 1.690

3.  The role of P2X7 purinergic receptors in inflammatory and nociceptive changes accompanying cyclophosphamide-induced haemorrhagic cystitis in mice.

Authors:  J P Martins; R B M Silva; R Coutinho-Silva; C M Takiya; A M O Battastini; F B Morrone; M M Campos
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

Review 4.  Laminin as a Biomarker of Blood-Brain Barrier Disruption under Neuroinflammation: A Systematic Review.

Authors:  Juan F Zapata-Acevedo; Valentina García-Pérez; Ricardo Cabezas-Pérez; Monica Losada-Barragán; Karina Vargas-Sánchez; Rodrigo E González-Reyes
Journal:  Int J Mol Sci       Date:  2022-06-17       Impact factor: 6.208

Review 5.  Purinergic signaling in oligodendrocyte development and function.

Authors:  Taylor G Welsh; Sarah Kucenas
Journal:  J Neurochem       Date:  2018-03-25       Impact factor: 5.372

6.  Contribution of pannexin1 to experimental autoimmune encephalomyelitis.

Authors:  Sarah E Lutz; Estibaliz González-Fernández; Juan Carlos Chara Ventura; Alberto Pérez-Samartín; Leonid Tarassishin; Hiromitsu Negoro; Naman K Patel; Sylvia O Suadicani; Sunhee C Lee; Carlos Matute; Eliana Scemes
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

7.  Emerging role of extracellular nucleotides and adenosine in multiple sclerosis.

Authors:  Marek Cieślak; Filip Kukulski; Michał Komoszyński
Journal:  Purinergic Signal       Date:  2011-07-27       Impact factor: 3.765

Review 8.  The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?

Authors:  Luiz E B Savio; Paola de Andrade Mello; Cleide Gonçalves da Silva; Robson Coutinho-Silva
Journal:  Front Pharmacol       Date:  2018-02-06       Impact factor: 5.810

Review 9.  The Impact of Purinergic System Enzymes on Noncommunicable, Neurological, and Degenerative Diseases.

Authors:  Margarete Dulce Bagatini; Alessandra Antunes Dos Santos; Andréia Machado Cardoso; Aline Mânica; Cristina Ruedell Reschke; Fabiano Barbosa Carvalho
Journal:  J Immunol Res       Date:  2018-08-12       Impact factor: 4.818

10.  Administration of an antagonist of P2X7 receptor to EAE rats prevents a decrease of expression of claudin-5 in cerebral capillaries.

Authors:  Tomasz Grygorowicz; Beata Dąbrowska-Bouta; Lidia Strużyńska
Journal:  Purinergic Signal       Date:  2018-08-08       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.